Munich, Stock

Munich Re Stock Plunges to 52-Week Low Despite 57% Profit Surge as CFO Faces Skeptics in Zurich

Veröffentlicht: 02.06.2026 um 04:05 Uhr, Redaktion boerse-global.de

Munich Re posted a 57% profit jump, but shares hit 52-week low amid 18.5% renewal volume drop and pricing pressure. CFO Buchanan speaks at Goldman Sachs conference.

At the Exact Moment Renk Hit a 52-Week Low, a Major Investor Shifted Its Position Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de
At the Exact Moment Renk Hit a 52-Week Low, a Major Investor Shifted Its Position Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

Chief Financial Officer Andrew Buchanan takes the stage at the Goldman Sachs European Financials Conference in Zurich today with the unenviable task of explaining why a near-record quarterly profit has done nothing to stop Munich Re's shares from sliding to their lowest level in a year. The stock closed at €446.50 on Monday, a fresh 52-week trough and a 26% plunge from the €605.00 high touched twelve months earlier. Year-to-date, the decline now stands at 18.67%.

The numbers on the table are striking. Munich Re posted a net profit of €1.714 billion for the first quarter of 2026, a 57% jump from the €1.094 billion reported a year earlier. The combined ratio in the core reinsurance business improved dramatically from 83.9% to 66.8%, driven by an unusually benign major-loss environment. Large claims fell to just €130 million, compared with more than €1 billion in the first quarter of 2025. The group reaffirmed its full-year net profit target of €6.3 billion on May 12.

Yet the market is unconvinced. The reason lies in the April renewal season, where Munich Re wrote €2.0 billion in volume—an 18.5% reduction from the prior period. Risk-adjusted prices declined 3.1% as the insurer deliberately walked away from business that did not meet its return thresholds. That discipline is admirable in theory, but it signals real pricing pressure in the reinsurance market. Investors worry that maintaining the €6.3 billion target now depends on a continuation of the benign claims environment that boosted the first quarter—a bet few are willing to make.

Should investors sell immediately? Or is it worth buying MĂĽnchener RĂĽck?

Buchanan's appearance in Zurich is not expected to produce new financial targets. Instead, the focus will be on how he bridges the gap between a confirmed earnings forecast and a weakening pricing backdrop. The dollar also complicates the picture: a stronger euro depresses reported premiums and profits, and Munich Re generates a significant portion of its business in US currency.

The group's financial position remains robust. Shareholders' equity reached €34.6 billion, while the Solvency II ratio stood at 292%, well above the strategic target range of 175% to 220%. That calculation already includes the current €2.25 billion share buyback program, the first tranche of €900 million of which started in mid-May and is expected to run until August. The ERGO primary insurance arm contributed €235 million to group earnings, slightly below the €241 million posted a year earlier, on revenue of €5.671 billion.

A small but notable vote of confidence came from board member Mari-Lizette Malherbe, who purchased 413 Munich Re shares in mid-May at an average price of €478.89, for a total of nearly €200,000. Insider buys are often seen as a bullish signal, though the stock has fallen further since then.

Taking a step back, the technical picture has clearly deteriorated. Over the past twelve months, Munich Re shares have lost 23.07% of their value. The next concrete milestones are the July renewal round and the half-year report scheduled for August 7. For now, all eyes are on Buchanan's tone in Zurich—especially regarding pricing—as the market waits to see whether the tension between strong operating performance and a sceptical share price can be resolved.

Ad

MĂĽnchener RĂĽck Stock: New Analysis - 2 June

Fresh MĂĽnchener RĂĽck information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated MĂĽnchener RĂĽck analysis...

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | DE0008430026 | MUNICH | boerse | 69467857 |